2006～2008年蛛网膜下腔出血患者用药情况分析  

Analysis of Drug Use of Patients with Subarachnoid Hemorrhage in Our Hospital from 2006 to 2008

作　　者：金振波[1] 朱传钧[2] 王莉文[1] 赵志刚[1] 

机构地区：[1]首都医科大学附属北京天坛医院药剂科,北京100050 [2]中国科学院上海有机化学研究所

出　　处：《药物流行病学杂志》2010年第5期273-275,共3页Chinese Journal of Pharmacoepidemiology

摘　　要：目的:研究我院2006～2008年蛛网膜下腔出血患者用药情况。方法:利用药历管理软件,对我院2006～2008年蛛网膜下腔出血患者使用药品的数量与金额进行统计,并计算DDDs、DDC和药品消耗金额排序(B)/DDDs排序(A)。结果:蛛网膜下腔出血患者最主要的治疗药物是心血管系统药物,抗感染药物、水,热量,电解质平衡药物和神经系统药物用量也较大。结论:我院在蛛网膜下腔出血的治疗中,药品使用基本合理。Objective： To investigate the drug use of patients with subarachnoid hemorrhage in our hospital from 2006 to 2008. Method： The amount and sum of drugs used in our hospital were summarized and analyzed. DDDs, DDC and B/A were calculated. Result： The primary drugs to treat subaraehnoid hemorrhage were the cardiovascular system drugs, anti-infective drugs, water, heat, electrolyte-balanced drugs and nervous system drugs. Conclusion： The use of drugs for the treatment of patients with subaraehnoid hemorrhage was reasonable in our hospital.

关 键 词：蛛网膜下腔出血 DDDS DDC 

分 类 号：R743.35[医药卫生—神经病学与精神病学]